- Home
- CVAC vs VSAT Comparison
CVAC vs VSAT Comparison
Compare CVAC & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- VSAT
- Stock Information
- Founded
- CVAC 2000
- VSAT 1986
- Country
- CVAC Germany
- VSAT United States
- Employees
- CVAC N/A
- VSAT N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- VSAT Radio And Television Broadcasting And Communications Equipment
- Sector
- CVAC Health Care
- VSAT Technology
- Exchange
- CVAC Nasdaq
- VSAT Nasdaq
- Market Cap
- CVAC 924.3M
- VSAT 1.2B
- IPO Year
- CVAC 2020
- VSAT 1996
- Fundamental
- Price
- CVAC $3.59
- VSAT $9.10
- Analyst Decision
- CVAC Hold
- VSAT Buy
- Analyst Count
- CVAC 3
- VSAT 7
- Target Price
- CVAC $10.00
- VSAT $17.00
- AVG Volume (30 Days)
- CVAC 1.2M
- VSAT 4.4M
- Earning Date
- CVAC 11-12-2024
- VSAT 02-06-2025
- Dividend Yield
- CVAC N/A
- VSAT N/A
- EPS Growth
- CVAC N/A
- VSAT N/A
- EPS
- CVAC N/A
- VSAT N/A
- Revenue
- CVAC $70,565,734.00
- VSAT $4,527,274,000.00
- Revenue This Year
- CVAC $742.57
- VSAT $7.71
- Revenue Next Year
- CVAC N/A
- VSAT $1.73
- P/E Ratio
- CVAC N/A
- VSAT N/A
- Revenue Growth
- CVAC 75.11
- VSAT 36.25
- 52 Week Low
- CVAC $2.22
- VSAT $6.69
- 52 Week High
- CVAC $5.28
- VSAT $26.70
- Technical
- Relative Strength Index (RSI)
- CVAC 45.89
- VSAT 47.83
- Support Level
- CVAC $3.70
- VSAT $7.45
- Resistance Level
- CVAC $4.09
- VSAT $9.85
- Average True Range (ATR)
- CVAC 0.22
- VSAT 1.04
- MACD
- CVAC -0.09
- VSAT -0.07
- Stochastic Oscillator
- CVAC 12.05
- VSAT 34.90
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About VSAT ViaSat Inc.
Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.